Intuitive Surgical, Inc. $ISRG Shares Acquired by Beacon Pointe Advisors LLC

Beacon Pointe Advisors LLC lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 48.8% during the second quarter, HoldingsChannel.com reports. The fund owned 6,185 shares of the medical equipment provider’s stock after acquiring an additional 2,029 shares during the period. Beacon Pointe Advisors LLC’s holdings in Intuitive Surgical were worth $3,361,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in Intuitive Surgical by 2.1% in the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after purchasing an additional 670,302 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Intuitive Surgical by 1.4% in the second quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after buying an additional 109,904 shares during the last quarter. Norges Bank purchased a new position in shares of Intuitive Surgical in the second quarter worth about $2,569,260,000. Invesco Ltd. boosted its position in Intuitive Surgical by 1.7% during the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after acquiring an additional 71,794 shares during the last quarter. Finally, Northern Trust Corp boosted its position in Intuitive Surgical by 0.3% during the first quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after acquiring an additional 11,988 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Down 0.2%

Shares of NASDAQ ISRG opened at $568.63 on Friday. The business’s 50 day moving average is $515.92 and its two-hundred day moving average is $505.59. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The firm has a market cap of $203.84 billion, a price-to-earnings ratio of 75.22, a PEG ratio of 5.24 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s revenue was up 22.9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.84 earnings per share. Analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the transaction, the chief executive officer owned 234,256 shares of the company’s stock, valued at approximately $128,266,872.80. This trade represents a 9.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the transaction, the executive vice president owned 5,758 shares of the company’s stock, valued at $3,310,850. This trade represents a 37.81% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 108,939 shares of company stock worth $60,757,995 over the last 90 days. 0.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts have commented on ISRG shares. Hsbc Global Res upgraded shares of Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. Raymond James Financial set a $603.00 price target on Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $599.00 to $600.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. BTIG Research boosted their price objective on Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Two analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $607.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.